Comparing Mortality Risk Predictive Ability of Different Scoring Systems in Cirrhotic Patients with Bacteremia

Table 2

Microbiological distribution, infection source, sepsis severity, and antimicrobial agent administration of cirrhotic patients with bacteremia (n = 127).

Characteristics	All (n = 127)	Nonsurvivors (n = 41)	Survivors (n = 86)	value
SIRS, n (%)	93 (73.2)	32 (78.0)	61 (70.9)	0.52
qSOFA score, n (%)
<2	86 (67.7)	20 (48.8)	66 (76.7)
≥2	41 (32.3)	21 (51.2)	20 (23.3)
Pitt bacteremia score, n (%)
<4	107 (84.3)	27 (65.9)	80 (93.0)
≥4	20 (15.7)	14 (34.1)	6 (7.0)
ACLF, n (%)	52 (40.9)	28 (68.3)	24 (27.9)
Number of organ failures, n (%)
0	45 (35.4)	3 (7.3)	42 (48.8)
1	33 (26.0)	7 (17.0)	26 (30.2)
2	38 (29.9)	20 (48.8)	18 (20.9)
≥3	11 (8.7)	11 (26.8)	0 (0)
CLIF-C OF score, mean ± SD	9 ± 2	11 ± 2	8 ± 1
Infection source, n (%)
Respiratory tract infection	8 (6.3)	4 (9.8)	4 (4.7)	0.27
Urinary tract infection	17 (13.4)	2 (4.9)	15 (17.4)	0.06
Spontaneous bacterial peritonitis	44 (34.6)	19 (46.3)	25 (29.1)	0.07
Biliary tract infection	27 (21.3)	10 (24.4)	17 (19.8)	0.64
Soft tissue infection	21 (16.5)	6 (14.6)	15 (17.4)	0.80
Primary bacteremia	10 (7.9)	0 (0)	10 (11.6)
Microbiological distribution, n (%)
Gram-positive pathogen	44 (34.6)	13 (31.7)	31 (36.0)	0.69
Staphylococcus aureus	14 (11.0)	6 (14.6)	8 (9.3)
Streptococcus pneumoniae	14 (11.0)	4 (9.8)	10 (11.6)
Viridans Streptococcus	5 (3.9)	1 (2.4)	4 (4.7)
Others	11 (8.7)	2 (4.9)	9 (10.5)
Gram-negative pathogen	73 (57.5)	27 (65.9)	46 (53.5)	0.25
Escherichia coli	27 (21.3)	11 (26.8)	16 (18.6)
Klebsiella pneumoniae	19 (15.0)	5 (12.2)	14 (16.3)
Pseudomonas aeruginosa	8 (6.3)	4 (9.8)	4 (4.7)
Others	19 (15.0)	7 (17.0)	12 (14.0)
Polymicrobial	10 (7.9)	1 (2.4)	9 (10.5)	0.17
Antimicrobial appropriateness, n (%)	92 (72.4)	27 (65.9)	65 (75.6)	0.65

SIRS: systemic inflammatory response syndrome. qSOFA: quick sequential organ failure assessment. ACLF: acute-on-chronic liver failure. CLIF-C OF: chronic liver failure consortium organ failure score.